Private EquityScreenerRefer

MARKET INSIGHTS

  • EventsNEWPrivate market milestones
  • NewsPrecize daily pulse
  • BlogsIn-depth articles and opinions

GUIDES

Explore Now
  • Unlisted SharesStep-by-step · KYC
  • BuyingStep-by-step · KYC
  • SellingExit in 24 - 48 hours
  • Pre-IPOReturns · risks · case studies
  • Tax GuideBudget 2026 changes
  1. Home
  2. Unlisted share news
  3. PharmEasy CEO Siddharth Shah steps down amid string of co-founder exits…

PharmEasy CEO Siddharth Shah steps down amid string of co-founder exits; Rahul Guha takes over

7 Aug 2025

Add as preferred source
Key Takeaways

Leadership shift and financial tightening signal operational refocus, but investors should watch for clarity on the revived IPO timeline.

Leadership shift and financial tightening signal operational refocus, but investors should watch for clarity on the revived IPO timeline.

pharmeasy unlisted shares

API Holdings (Pharmeasy)

-8.09%

Expert Analysis

API Holdings Appoints Rahul Guha as CEO Amid Leadership Restructuring and Financial Refocus.

Expert Analysis :

  • Leadership Transition: API Holdings has appointed Rahul Guha as Managing Director and CEO, effective August 27, 2025, replacing co-founder Siddharth Shah, who becomes Vice Chairman.

  • Management Background: Guha, currently CEO of Thyrocare and President of Operations at API, will continue both roles while leading API.

  • Financial Snapshot: In FY24, revenue declined 15 percent YoY to $660 million while net losses reduced to $300 million due to cost controls.

  • Valuation Decline: PharmEasy’s valuation fell from $5.6 billion to $700 million during a $216 million fundraise in April 2024.

  • Strategic Outlook: Guha's appointment signals a focus on operational execution and profitability. An IPO is still planned, with no set timeline.

Publisher:Money Control